Francis Lo's most recent trade in Adaptive Biotechnologies Corp was a trade of 105,762 Common Stock done at an average price of $22.6 . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 22.59 per share. | 15 Jul 2026 | 105,762 | 230,713 (0%) | 0% | 22.6 | 2,389,164 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 59,374 | 0 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 15 Jul 2026 | 59,374 | 290,087 (0%) | 0% | 7.8 | 463,117 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 23,677 | 132,246 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 15 Jul 2026 | 23,677 | 313,764 (0%) | 0% | 12.1 | 287,439 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 22,711 | 37,511 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 15 Jul 2026 | 22,711 | 336,475 (0%) | 0% | 8.5 | 192,135 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 22.59 per share. | 01 Jul 2026 | 44,838 | 230,713 (0%) | 0% | 22.6 | 1,012,890 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 22.50 per share. | 01 Jul 2026 | 42,261 | 237,688 (0%) | 0% | 22.5 | 950,873 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 14,064 | 126,584 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.12 per share. | 01 Jul 2026 | 14,064 | 288,692 (0%) | 0% | 8.1 | 114,200 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 12,637 | 60,222 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 01 Jul 2026 | 12,637 | 275,551 (0%) | 0% | 8.5 | 106,909 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 12,626 | 59,374 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 01 Jul 2026 | 12,626 | 250,314 (0%) | 0% | 7.8 | 98,483 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 12,600 | 155,923 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 01 Jul 2026 | 12,600 | 262,914 (0%) | 0% | 12.1 | 152,964 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 12,206 | 72,859 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 01 Jul 2026 | 12,206 | 269,940 (0%) | 0% | 8.5 | 103,263 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 22.18 per share. | 01 Jul 2026 | 8,743 | 279,949 (0%) | 0% | 22.2 | 193,920 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 4,688 | 81,265 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 01 Jul 2026 | 4,688 | 274,628 (0%) | 0% | 4.0 | 18,705 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 01 Jul 2026 | 3,500 | 254,434 (0%) | 0% | 7.8 | 27,300 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 3,500 | 72,000 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 01 Jul 2026 | 3,300 | 257,734 (0%) | 0% | 12.1 | 40,062 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 3,300 | 168,523 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 17.49 per share. | 04 Jun 2026 | 39,741 | 250,934 (0%) | 0% | 17.5 | 695,070 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2026 | 9,376 | 140,648 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.12 per share. | 04 Jun 2026 | 9,376 | 290,675 (0%) | 0% | 8.1 | 76,133 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 04 Jun 2026 | 5,792 | 276,946 (0%) | 0% | 12.1 | 70,315 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2026 | 5,792 | 171,823 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2026 | 2,344 | 85,953 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 04 Jun 2026 | 2,344 | 281,299 (0%) | 0% | 4.0 | 9,353 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2026 | 2,009 | 85,065 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 04 Jun 2026 | 2,009 | 278,955 (0%) | 0% | 8.5 | 16,996 | Common Stock |
| United Rentals | Francisco J. Lopez-Balboa | Director | Grant, award, or other acquisition of securities at price $ 937.00 per share. | 08 May 2026 | 203 | 1,605 (0%) | 0% | 937 | 190,211 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 08 Apr 2026 | 22,564 | 271,154 (0%) | 0% | 15.1 | 340,039 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2026 | 2,344 | 88,297 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 08 Apr 2026 | 2,344 | 293,718 (0%) | 0% | 4.0 | 9,353 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 14.08 per share. | 11 Mar 2026 | 30,593 | 291,374 (0%) | 0% | 14.1 | 430,749 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 15.09 per share. | 05 Mar 2026 | 38,074 | 321,967 (0%) | 0% | 15.1 | 574,537 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 44,063 | 360,041 (0%) | 0% | 0 | Common Stock | |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.19 per share. | 09 Feb 2026 | 490 | 63,393 (0%) | 0% | 212.2 | 103,973 | common stock |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 215.73 per share. | 09 Feb 2026 | 449 | 63,883 (0%) | 0% | 215.7 | 96,863 | common stock |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 9,389 | 66,313 (0%) | 0% | 0 | common stock | |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.50 per share. | 06 Feb 2026 | 3,729 | 62,584 (0%) | 0% | 217.5 | 811,058 | common stock |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 2,114 | 64,698 (0%) | 0% | 0 | common stock | |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.50 per share. | 06 Feb 2026 | 366 | 64,332 (0%) | 0% | 217.5 | 79,605 | common stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 17.73 per share. | 12 Jan 2026 | 79,590 | 315,978 (0%) | 0% | 17.7 | 1,411,131 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 12 Jan 2026 | 36,650 | 352,628 (0%) | 0% | 7.8 | 285,870 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 36,650 | 75,500 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 12 Jan 2026 | 21,002 | 381,353 (0%) | 0% | 8.5 | 177,677 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 21,002 | 87,074 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 14,215 | 90,641 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 12 Jan 2026 | 14,215 | 395,568 (0%) | 0% | 4.0 | 56,718 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 12 Jan 2026 | 7,723 | 360,351 (0%) | 0% | 12.1 | 93,757 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 7,723 | 177,615 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 02 Jan 2026 | 3,125 | 319,103 (0%) | 0% | 4.0 | 12,469 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 16.08 per share. | 02 Jan 2026 | 3,125 | 315,978 (0%) | 0% | 16.1 | 50,250 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 3,125 | 104,856 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 22 Dec 2025 | 4,394 | 315,978 (0%) | 0% | 17.5 | 76,895 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 22 Dec 2025 | 4,394 | 315,978 (0%) | 0% | 17.5 | 76,895 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 2,194 | 106,982 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 22 Dec 2025 | 2,194 | 319,272 (0%) | 0% | 8.5 | 18,561 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 2,194 | 107,981 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 22 Dec 2025 | 2,194 | 320,372 (0%) | 0% | 4.0 | 8,754 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 22 Dec 2025 | 1,100 | 317,078 (0%) | 0% | 7.8 | 8,580 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 1,100 | 109,075 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 1,100 | 112,150 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 22 Dec 2025 | 1,100 | 320,372 (0%) | 0% | 4.0 | 4,389 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 22 Dec 2025 | 1,100 | 317,078 (0%) | 0% | 7.8 | 8,580 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 1,100 | 108,076 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 1,100 | 112,150 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 22 Dec 2025 | 1,100 | 318,178 (0%) | 0% | 8.5 | 9,306 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 15.57 per share. | 15 Dec 2025 | 113,890 | 315,978 (0%) | 0% | 15.6 | 1,773,267 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 39,849 | 110,175 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 15 Dec 2025 | 39,849 | 429,868 (0%) | 0% | 4.0 | 158,998 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 15 Dec 2025 | 37,750 | 370,596 (0%) | 0% | 7.8 | 294,450 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 37,750 | 113,250 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 19,423 | 109,176 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 15 Dec 2025 | 19,423 | 390,019 (0%) | 0% | 8.5 | 164,319 | Common Stock |
| United Rentals | Francisco J. Lopez-Balboa | Director | Grant, award, or other acquisition of securities at price $ 670.00 per share. | 08 May 2025 | 284 | 1,402 (0%) | 0% | 670 | 190,280 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 150,024 | 150,024 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 99,976 | 353,721 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 13,790 | 332,846 (0%) | 0% | 7.0 | 96,392 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 7,085 | 346,636 (0%) | 0% | 7.0 | 49,453 | Common Stock |
| Cumulus Media Inc. - Ordin... | Francisco J. Lopez-Balboa | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 18,005 | 507,134 (3%) | 0% | 0 | Class A Common Stock, par value $0.0000001 per share | |
| Cumulus Media Inc. - Ordin... | Francisco J. Lopez-Balboa | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 21 Feb 2025 | 14,178 | 492,956 (3%) | 0% | 0 | Class A Common Stock, par value $0.0000001 per share | |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 13,044 | 60,823 (0%) | 0% | 0 | common stock | |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.93 per share. | 07 Feb 2025 | 5,176 | 55,647 (0%) | 0% | 157.9 | 817,446 | common stock |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 2,786 | 58,433 (0%) | 0% | 0 | common stock | |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 158.18 per share. | 07 Feb 2025 | 571 | 56,924 (0%) | 0% | 158.2 | 90,321 | common stock |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.51 per share. | 07 Feb 2025 | 490 | 57,495 (0%) | 0% | 157.5 | 77,180 | common stock |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.93 per share. | 07 Feb 2025 | 448 | 57,985 (0%) | 0% | 157.9 | 70,753 | common stock |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Sale of securities on an exchange or to another person at price $ 139.32 per share. | 01 Aug 2024 | 12,730 | 47,779 (0%) | 0% | 139.3 | 1,773,544 | common stock |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 12,730 | 0 | - | - | Stock Option (right to buy) | |
| Ryder System Inc | Francisco Lopez | EVP & Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 76.49 per share. | 01 Aug 2024 | 12,730 | 60,509 (0%) | 0% | 76.5 | 973,718 | common stock |
| United Rentals | Francisco J. Lopez-Balboa | Director | Grant, award, or other acquisition of securities at price $ 689.21 per share. | 09 May 2024 | 254 | 1,118 (0%) | 0% | 689.2 | 175,059 | Common Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 150,024 | 150,024 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 99,976 | 268,445 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 04 Mar 2024 | 12,887 | 255,558 (0%) | 0% | 3.4 | 44,202 | Common Stock |